NDC 72104-843

Lionesse Opal Sheer Shield SPF 30

Octinoxate, Homosalate, Octisalate, Oxybenzone, Avobenzone

Lionesse Opal Sheer Shield SPF 30 is a Topical Lotion in the Human Otc Drug category. It is labeled and distributed by Lionesse Usa Inc.. The primary component is Octinoxate; Homosalate; Octisalate; Oxybenzone; Avobenzone.

Product ID72104-843_fd0419a8-7275-42b2-b126-91735b9c0292
NDC72104-843
Product TypeHuman Otc Drug
Proprietary NameLionesse Opal Sheer Shield SPF 30
Generic NameOctinoxate, Homosalate, Octisalate, Oxybenzone, Avobenzone
Dosage FormLotion
Route of AdministrationTOPICAL
Marketing Start Date2017-11-15
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart352
Labeler NameLIONESSE USA INC.
Substance NameOCTINOXATE; HOMOSALATE; OCTISALATE; OXYBENZONE; AVOBENZONE
Active Ingredient Strength7 g/100g; g/100g; g/100g; g/100g; g/100g
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 72104-843-12

1 JAR in 1 CARTON (72104-843-12) > 50 g in 1 JAR
Marketing Start Date2017-11-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72104-843-12 [72104084312]

Lionesse Opal Sheer Shield SPF 30 LOTION
Marketing CategoryOTC monograph not final
Application Numberpart352
Product TypeHUMAN OTC DRUG
Marketing Start Date2017-11-15
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
OCTINOXATE7.4 g/100g

OpenFDA Data

SPL SET ID:fd0419a8-7275-42b2-b126-91735b9c0292
Manufacturer
UNII

NDC Crossover Matching brand name "Lionesse Opal Sheer Shield SPF 30" or generic name "Octinoxate, Homosalate, Octisalate, Oxybenzone, Avobenzone"

NDCBrand NameGeneric Name
72104-843Lionesse Opal Sheer Shield SPF 30Octinoxate, Homosalate, Octisalate, Oxybenzone, Avobenzone
72104-362Nova Bright Skin SPF 30Octinoxate, Homosalate, Octisalate, Oxybenzone, Avobenzone
69201-874Venofye Orchard Bee Brilliance SPF 30Octinoxate, Homosalate, Octisalate, Oxybenzone, Avobenzone

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.